May 14, 2013
Danaher won't stay stuck for long.
October 11, 2012
The morning has been good for the market. The Nasdaq has climbed 0.3%; the S&P 500 has moved up 0.6%; and the Dow is up ...
June 22, 2012
The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
May 3, 2012
Mixed 1Q for Luminex, Profits Down - Analyst Blog
March 29, 2012
The Affordable Care Act finally goes in front of the Supreme Court. However, the Justice’s ruling may not matter. Healthcare ...
December 30, 2011
Neogen has to do more to validate this price.
August 2, 2011
Cepheid is becoming a real player in MDx, but the valuation is way ahead.
July 5, 2011
Immucor gets a fair price for its shareholders.
October 7, 2010
This company has the right technology and product mix to succeed, but now it has to show it has the capabilities to match.
September 28, 2010
Food safety scares bring new attention to a proven performer.